REQUEST A DEMO
Total
USD $0.00
FAQ
Secure shopping

Healthcare and pharma

The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.

The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.

2 3 4 5 6 14
USD 495 Date: May 2022 Language: English
Format: PDF
Add to basket
USD 495 Date: May 2022 Language: English
Format: PDF
Add to basket
EMIS Insights India Pharma and Healthcare Sector Report 2022-2023 - Page 1
EMIS Insights India Pharma and Healthcare Sector Report 2022-2023 EMIS Insights Industry Reports

India’s pharmaceuticals and healthcare sector has a global reputation. India accounts for approximately 20% of the worldwide market share of generic drugs, making it the leading exporter, particularly to the developing world. India is ...

View more details
USD 495 Date: March 2022 Language: English
Format: PDF
Add to basket
Chile Pharma and Healthcare Sector Report 2022-2023 - Page 1
Chile Pharma and Healthcare Sector Report 2022-2023 EMIS Insights Industry Reports

In the context of Latin America, Chile is not a particularly large pharmaceutical and healthcare market as its population is relatively small and healthy in terms of incidence of communicable diseases. However, the country’s changing ...

View more details
USD 495 Date: March 2022 Language: English
Format: PDF
Add to basket
Brazil Pharma and Healthcare Sector Report 2022-2023 - Page 1
Brazil Pharma and Healthcare Sector Report 2022-2023 EMIS Insights Industry Reports

The COVID-19 pandemic underlined the inefficiencies of the Brazilian pharmaceutical and healthcare sector. In drug manufacturing, many pharmaceutical companies took a hit in profitability. They struggled to meet demand as global supply chains were ...

View more details
USD 495 Date: March 2022 Language: English
Format: PDF
Add to basket
Thailand Pharma and Healthcare Sector Report 2022-2023 - Page 1
Thailand Pharma and Healthcare Sector Report 2022-2023 EMIS Insights Industry Reports

Thailand’s pharmaceuticals and healthcare sector has developed considerably over the past few decades. The Thai government initiated its plan to deliver universal healthcare to all Thais in 2002, which has proven so successful that more than 99 ...

View more details
USD 495 Date: March 2022 Language: English
Format: PDF
Add to basket
Russia Pharma and Healthcare Sector Report 2022-2023 - Page 1
Russia Pharma and Healthcare Sector Report 2022-2023 EMIS Insights Industry Reports

Russia’s healthcare expenditure grew significantly in 2020, mainly reflecting increased spending related to the COVID-19 pandemic. Total spending on healthcare surged by nearly a fifth to RUB 6.2tn in 2020, equal to 5.8% of the country’s ...

View more details
USD 495 Date: February 2022 Language: English
Format: PDF
Add to basket
Malaysia Pharma and Healthcare Sector Report 2022-2023 - Page 1
Malaysia Pharma and Healthcare Sector Report 2022-2023 EMIS Insights Industry Reports

Malaysia has a highly developed pharmaceuticals and healthcare sector. Malaysia’s healthcare system is two-tiered. The Ministry of Health (“MoH”) provides comprehensive, taxpayer-funded healthcare services for Malaysian ...

View more details
USD 495 Date: January 2022 Language: English
Format: PDF
Add to basket
China Healthcare Sector Report 2021 4th Quarter - Page 1
China Healthcare Sector Report 2021 4th Quarter EMIS Insights Industry Reports

In Q3 2021, Chinese residents’ expenditures on medicine and medical services continued to increase. Per capita spending of urban residents reached RMB 635, up by 10.8% y/y, and that of rural residents recorded a growth of 9 ...

View more details
USD 495 Date: January 2022 Language: English
Format: PDF
Add to basket
China Healthcare Sector Report 2021 3rd Quarter - Page 1
China Healthcare Sector Report 2021 3rd Quarter EMIS Insights Industry Reports

As the global epidemic is being contained and China’s economic growth has returned to normal, the growth of the country's healthcare sector is likely to gradually slow down to pre-pandemic levels. In the second quarter of 2021, the ...

View more details
USD 495 Date: November 2021 Language: English
Format: PDF
Add to basket
2 3 4 5 6 14